Showing results (31-40 of 98) with videos related to
Sort By:
Pageof 10
Oncology Reports|April 8, 2004
Genome-wide cDNA microarray screening to correlate gene expression profile with survival in patients with advanced lung cancerMizuki Ikehara, Fumihiro Oshita, Akiko Sekiyama, et al.Biomedical Research (Tokyo, Japan)|June 21, 2013
Prognostic value of organic anion transporting polypeptide 1B3 and copper transporter 1 expression in endometrial cancer patients treated with paclitaxel and carboplatinNaoki Ogane, Masanori Yasuda, Yoichi Kameda, et al.Journal of Computer Assisted Tomography|February 4, 2009
Initial findings and progression of lung adenocarcinoma on serial computed tomography scansHaruhiro Saito, Kouzo Yamada, Nobuyuki Hamanaka, et al.Journal of Experimental Therapeutics & Oncology|October 27, 2004
Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancerFumihiro Oshita, Mizuki Ikehara, Akiko Sekiyama, et al.Oncology Letters|September 12, 2012
Surgical outcomes and reevaluation of treatment strategies for thymomasHiroyuki Ito, Haruhiko Nakayama, Masahiro Tsuboi, et al.Journal of Gastroenterology and Hepatology|August 31, 2002
Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinomaSoichiro Morinaga, Yuji Yamamoto, Yoshikazu Noguchi, et al.Diagnostic Pathology|February 19, 2013
Endometrial intraepithelial carcinoma in association with polyp: review of eight casesMasanori Yasuda, Tomomi Katoh, Shinichi Hori, et al.Journal of Computer Assisted Tomography|June 4, 2008
Prognosis of small adenocarcinoma of the lung based on thin-section computed tomography and pathological preparationsMizuki Ikehara, Haruhiro Saito, Kouzo Yamada, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|October 12, 2016
Peritoneal sarcoidosis:an unusual cause of ascitesYosuke Kunishi, Koichiro Yoshie, Mitsuyasu Ota, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|December 14, 2011
WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitorsYuji Sakuma, Yukiko Yamazaki, Yoshiyasu Nakamura, et al.Pageof 10